Stock Scorer

ACCENDRA HEALTH INC/VA/ (ACH)

ACCENDRA HEALTH INC/VA/ reported revenue of 613.2M USD for the quarter ending 30 June 2026, down 10.1% from 681.9M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 613.2M -10.1%
Gross Profit Q1 '25 · ending 31 March 2025 526M -1.8%
Operating Income Q2 '26 · ending 30 June 2026 -35.1M —
Net Income Q2 '26 · ending 30 June 2026 -89.1M —
Cost of Revenue Q2 '26 · ending 30 June 2026 349.8M -2.1%
Operating Cash Flow Q2 '26 · ending 30 June 2026 -26M -169.1%
Free Cash Flow Q2 '26 · ending 30 June 2026 -73.6M —
Shares Outstanding Q2 '26 · ending 30 June 2026 76.7M -0.7%
EPS Q2 '26 · ending 30 June 2026 -3.94 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 2.8B27.5M-1.1B-292.7M
20242024-12-31 2.7B-217.7M-362.7M-8.8M
20232023-12-31 2.6B133.2M-41.3M568.3M
20222022-12-31 10B142.9M22.4M166.9M
20212021-12-31 9.8B368.5M221.6M83.2M
20202020-12-31 8.5B204.1M29.9M288.8M
20192019-12-31 9.2B73.2M-62.4M123.7M
20182018-12-31 9.4B-352.3M-437M70.7M
20172017-12-31 9.3B89.3M72.8M22.2M
20162016-12-31 9.7B199.6M108.8M167.4M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-30613.2M
Q1 '262026-03-31627.8M
Q4 '252025-12-31709M
Q3 '252025-09-30697.3M
Q2 '252025-06-30681.9M
Q1 '252025-03-31673.9M
Q4 '242024-12-31695M
Q3 '242024-09-30686.8M
Q2 '242024-06-30660.4M
Q1 '242024-03-312.6B
Q3 '232023-09-302.6B
Q2 '232023-06-302.6B
Q1 '232023-03-312.5B
Q4 '222022-12-312.6B
Q3 '222022-09-302.5B
Q2 '222022-06-302.5B
Q1 '222022-03-312.4B
Q4 '212021-12-312.5B
Q3 '212021-09-302.5B
Q2 '212021-06-302.5B

Gross Profit Quarterly

PeriodEndingGross Profit
Q1 '252025-03-31526M
Q4 '242024-12-31579.8M
Q3 '242024-09-30559.7M
Q2 '242024-06-30544.2M
Q1 '242024-03-31535.5M
Q4 '232023-12-31569.9M
Q3 '232023-09-30538.5M
Q2 '232023-06-30519.4M
Q1 '232023-03-31497.3M
Q4 '222022-12-31407.1M
Q3 '222022-09-30513.3M
Q2 '222022-06-30532.5M
Q1 '222022-03-31373.4M
Q4 '212021-12-31341.6M
Q3 '212021-09-30328.8M
Q2 '212021-06-30400.1M
Q1 '212021-03-31442.8M
Q4 '202020-12-31398.5M
Q3 '202020-09-30344.3M
Q2 '202020-06-30269.4M

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30-35.1M
Q1 '262026-03-3117.1M
Q4 '252025-12-3120.9M
Q3 '252025-09-3026.5M
Q2 '252025-06-30-39.7M
Q1 '252025-03-3119.8M
Q4 '242024-12-31-272.7M
Q3 '242024-09-3031.1M
Q2 '242024-06-3016.9M
Q1 '242024-03-319.7M
Q4 '232023-12-3188.7M
Q3 '232023-09-3023.8M
Q2 '232023-06-3010.8M
Q1 '232023-03-319.8M
Q3 '222022-09-3060.2M
Q2 '222022-06-3075.1M
Q1 '222022-03-3161.1M
Q4 '212021-12-3162M
Q3 '212021-09-3062.9M
Q2 '212021-06-3096.9M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-89.1M
Q1 '262026-03-31-6.5M
Q4 '252025-12-31-56.3M
Q3 '252025-09-30-150.3M
Q2 '252025-06-30-869.1M
Q1 '252025-03-31-25M
Q4 '242024-12-31-296.1M
Q3 '242024-09-30-12.8M
Q2 '242024-06-30-31.9M
Q1 '242024-03-31-21.9M
Q4 '232023-12-3117.8M
Q3 '232023-09-30-6.4M
Q2 '232023-06-30-28.2M
Q1 '232023-03-31-24.4M
Q3 '222022-09-3012.5M
Q2 '222022-06-3028.6M
Q1 '222022-03-3139.3M
Q4 '212021-12-3142M
Q3 '212021-09-3044.1M
Q2 '212021-06-3065.9M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-30349.8M
Q1 '262026-03-31349.8M
Q4 '252025-12-31385.7M
Q3 '252025-09-30375.1M
Q2 '252025-06-30357.3M
Q1 '252025-03-31354.6M
Q4 '242024-12-31324.4M
Q3 '242024-09-30355.1M
Q2 '242024-06-30344.4M
Q1 '242024-03-312.1B
Q3 '232023-09-302.1B
Q2 '232023-06-302B
Q1 '232023-03-312B
Q4 '222022-12-312.1B
Q3 '222022-09-302B
Q2 '222022-06-302B
Q1 '222022-03-312B
Q4 '212021-12-312.1B
Q3 '212021-09-302.2B
Q2 '212021-06-302.1B

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30-26M
Q1 '262026-03-31-50.1M
Q4 '252025-12-3168.2M
Q3 '252025-09-30-172.5M
Q2 '252025-06-3037.6M
Q1 '252025-03-31-35.1M
Q4 '242024-12-3171M
Q3 '242024-09-3027.3M
Q2 '242024-06-30116.1M
Q1 '242024-03-31-53M
Q4 '232023-12-31111.8M
Q3 '232023-09-30157.4M
Q2 '232023-06-30313.1M
Q1 '232023-03-31158.4M
Q4 '222022-12-3187M
Q3 '222022-09-3068.5M
Q2 '222022-06-3089.8M
Q1 '222022-03-3179.7M
Q4 '212021-12-3150.3M
Q3 '212021-09-3061.4M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-30-73.6M
Q1 '262026-03-31-91.7M
Q4 '252025-12-3155.1M
Q3 '252025-09-30-246.9M
Q2 '252025-06-30-20M
Q1 '252025-03-31-80.9M
Q4 '242024-12-3148.7M
Q3 '242024-09-30-30.3M
Q2 '242024-06-3071.8M
Q1 '242024-03-31-99M
Q4 '232023-12-3179.9M
Q3 '232023-09-30109.7M
Q2 '232023-06-30266.5M
Q1 '232023-03-31112.2M
Q4 '222022-12-3138.1M
Q3 '222022-09-3021.5M
Q2 '222022-06-3037.2M
Q1 '222022-03-3170.1M
Q4 '212021-12-3135.8M
Q3 '212021-09-3049.6M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-3076.7M
Q1 '262026-03-3176.4M
Q3 '252025-09-3077.3M
Q2 '252025-06-3076.9M
Q1 '252025-03-3177.3M
Q3 '242024-09-3078.5M
Q2 '242024-06-3076.7M
Q1 '242024-03-3176.3M
Q3 '232023-09-3076.2M
Q2 '232023-06-3075.8M
Q1 '232023-03-3175.2M
Q3 '222022-09-3076.4M
Q2 '222022-06-3076.3M
Q1 '222022-03-3176M
Q3 '212021-09-3076M
Q2 '212021-06-3075.8M
Q1 '212021-03-3170.9M
Q3 '202020-09-3060.9M
Q2 '202020-06-3061.1M
Q1 '202020-03-3160.6M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-30-3.94
Q1 '262026-03-31-14.08
Q4 '252025-12-31-14.32
Q3 '252025-09-30-17.42
Q2 '252025-06-30-15.64
Q1 '252025-03-31-4.76
Q4 '242024-12-31-4.73
Q3 '242024-09-30-0.63
Q2 '242024-06-30-0.55
Q1 '242024-03-31-0.50
Q4 '232023-12-31-0.53
Q3 '222022-09-301.61
Q2 '222022-06-302.03
Q1 '222022-03-312.53
Q4 '212021-12-312.99
Q3 '212021-09-303.24
Q2 '212021-06-303.42
Q1 '212021-03-311.64
Q4 '202020-12-310.47
Q3 '202020-09-30-0.98